Skip to main content
. 2021 May 28;11(6):802. doi: 10.3390/biom11060802

Figure 6.

Figure 6

Stable interactions observed during MD refinement of top binding poses of compound 5 (left) and 6 (right) with SARS-CoV-2 Plpro. The inhibitors are shown in ball and stick representation, stable and moderately stable ligand-protein interactions are represented as thick tubes, short time interactions (less than 30%) are represented as thin tubes.